Fursultiamine

From WikiMD's WELLNESSPEDIA

Fursultiamine

Fursultiamine (INN: Adventan, Alinamin-F, Benlipoid, Bevitol Lipophil, Judolor), commonly identified as thiamine tetrahydrofurfuryl disulfide (TTFD), is an allithiamine or a disulfide derivative of thiamine.

History[edit]

Fursultiamine was initially synthesized in Japan during the 1960s with the intention of formulating variants of thiamine that exhibited enhanced lipophilicity. This was aimed at addressing and treating vitamin B1 deficiencies, specifically beriberi. Following its synthesis, it was subsequently commercialized in several countries including Japan, Spain, Austria, Germany, and the United States. Being a vitamin, it is also readily accessible over-the-counter.

Clinical Uses and Research[edit]

Apart from its primary indication to treat avitaminosis, fursultiamine has undergone clinical trials for potential use in the treatment of Alzheimer's disease and autistic spectrum disorders. While results indicated a certain level of benefit, they were deemed to be relatively modest. Fursultiamine has also been examined for its potential to enhance energy metabolism during exercise and mitigate exercise-induced fatigue. However, results from such studies have been inconclusive, showcasing both supporting and conflicting evidence.

Available Brands[edit]

  • Privitamix softgel (Available in India)

See also[edit]


Vitamins[edit]

A[edit]

B[edit]

C[edit]

D[edit]

E[edit]

F[edit]

I[edit]

K[edit]

M[edit]

N[edit]

P[edit]

R[edit]

S[edit]

T[edit]

V[edit]

Z[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.